New look at the old management of unknown primary

Journal of Surgical Oncology

Volumn 98, Issue 2, 2008, Pages 71-72

  Dowden, Scot ^a,c,d,e,f   Miller, Walter ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c Medicine and Oncology

^d Gastrointestinal Tumour Group

^e Medical Oncology Training Program

^f NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

AUTOPSY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; IMMUNOHISTOCHEMISTRY; METASTASIS; OCCULT CANCER; OVARY CANCER; PATIENT CARE; PERITONEUM CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE;

EID: 49149130817     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20995     Document Type: Editorial

References (11)

1. Muir C: Cancer of unknown primary site. Cancer 1995;75:353-356.
2. Pentheroudakis G, Golfinopoulos V, Pavlidis N.: Switching benchmarks in cancer of unknown primary; From autopsy to microarray. Eur J Cancer 2007;43:2026-2036.
3. Levine MN, Drummond MF, Labelle RJ.: Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin. Can Med Assoc J 133:977-987.
4. ASCO Plenary Session, Proc ASCO 2007.
5. Ambosini V, Nanni C, Rubello D, et al.: 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin. Radiol Med (Torino) 2006;111:1146-1155.
6. Garin E, Prigent-Lejeune F, Lesimple T, et al.: Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary. Cancer Invest 2007;25:232-239.
7. Silva P, Hulse P, Sykes AJ, et al.: Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary? J Laryngol Otol 2007;121:149-153.
8. Ekberg T, Sörensen J, Engström M, et al.: Clinical impact of positron emission tomography (PET) with (18F) fluorodeoxyglucose (FDG) in head and neck tumours. Acta Otolaryngol 2007;127:186-193.
9. Hainsworth JD: Carcinoma of Unknown Primary Site: Current Treatment Recommendations. ASCO Educational Book. ASCO. 2004.
10. Greco FA, Burris HA III, Litchy S, et al.: Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. J Clin Oncol 2002;20:1651-1656.
11. Tournigand C, André T, Achille E, et al.: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004;22:229-237.